WebApr 14, 2024 · Regev is a founder of and equity holder in Celsius Therapeutics, an equity holder in Immunitas Therapeutics, and a scientific advisory board (SAB) member of Syros Pharmaceuticals, ThermoFisher Scientific, Asimov, and … WebMar 7, 2024 · Leif S Ludwig 1 , Caleb A Lareau 2 , Jacob C Ulirsch 3 , Elena Christian 4 , Christoph Muus 5 , Lauren H Li 6 , Karin Pelka 7 , Will Ge 4 , Yaara Oren 8 , Alison Brack 4 , Travis Law 4 , Christopher Rodman 4 , Jonathan H Chen 9 , Genevieve M Boland 10 , Nir Hacohen 7 , Orit Rozenblatt-Rosen 4 , Martin J Aryee 11 , Jason D Buenrostro 12 , …
Lineage Tracing in Humans Enabled by Mitochondrial Mutations …
WebJun 1, 2024 · Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Program in Biological and Biomedical Sciences, Harvard University, Cambridge, MA 02138, USA. 1 … WebDeveloper of a drug intended to discover new small molecule therapeutics. The company's platform focuses on identifying and studying rare cell types to forge entirely new avenues … sql server scripting jobs
Home Page Harvard John A. Paulson School of …
WebMar 17, 2024 · Christoph Muus. Massachusetts Institute of Technology and Harvard University - Broad Institute. Marc H. Wadsworth II. Massachusetts Institute of … WebNational Center for Biotechnology Information WebHead, Executive Vice President, Genentech Research and Early Development Postdoc Mentor 3 Years at Genentech 67 Publications at Genentech 20 Awards & Honors I joined Genentech in August 2024 as Head and Executive Vice President, Genentech Research and Early Development. sherlings men coat back in style